n-methyl-3,4-methylenedioxyamphetamine and Bewilderment studies

n-methyl-3,4-methylenedioxyamphetamine and Bewilderment

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Research Excerpts

Excerpt	Relevance	Reference
"The dependent variable was the number of reported ecstasy-related adverse effects."	1.37	Modelling the adverse effects associated with ecstasy use. ( Fisk, JE; Hadjiefthyvoulou, F; Montgomery, C; Murphy, PN, 2011)

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

0 (0.00)

18.2507

2000's

1 (33.33)

29.6817

2010's

2 (66.67)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Fisk, JE	1
Murphy, PN	1
Montgomery, C	1
Hadjiefthyvoulou, F	1
Claffey, C	1
Cami, J	1
Farré, M	1
Mas, M	1
Roset, PN	1
Poudevida, S	1
Mas, A	1
San, L	1
de la Torre, R	1

Studies

Fisk, JE

Murphy, PN

Montgomery, C

Hadjiefthyvoulou, F

Claffey, C

Cami, J

Farré, M

Mas, M

Roset, PN

Poudevida, S

Mas, A

San, L

de la Torre, R

Clinical Trials (1)

Trial Overview

Trial	Phase	Enrollment	Study Type	Start Date	Status
The Effects of MDMA on Prefrontal and Amygdala Activation in Posttraumatic Stress Disorder[NCT03752918]	Phase 1	20 participants (Anticipated)	Interventional	2024-01-31	Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial

Phase

Enrollment

Study Type

Start Date

Status

The Effects of MDMA on Prefrontal and Amygdala Activation in Posttraumatic Stress Disorder[NCT03752918]

Phase 1

20 participants (Anticipated)

Interventional

2024-01-31

Not yet recruiting

[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

Article	Year
Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): psychomotor performance and subjective effects. Journal of clinical psychopharmacology, 2000, Volume: 20, Issue:4 Topics: Adult; Affect; Confusion; Cross-Over Studies; Double-Blind Method; Hallucinogens; Humans; Male; N-Me	2000

Article

Year

Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): psychomotor performance and subjective effects.

Journal of clinical psychopharmacology, 2000, Volume: 20, Issue:4

Topics: Adult; Affect; Confusion; Cross-Over Studies; Double-Blind Method; Hallucinogens; Humans; Male; N-Me

2000

Other Studies

2 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Bewilderment

Article	Year
Modelling the adverse effects associated with ecstasy use. Addiction (Abingdon, England), 2011, Volume: 106, Issue:4 Topics: Affect; Alcohol Drinking; Anxiety; Binomial Distribution; Confusion; Dose-Response Relationship, Dru	2011
A 26-year-old woman with sudden onset cerebral edema. Journal of emergency nursing, 2011, Volume: 37, Issue:1 Topics: Acute Disease; Adult; Brain Edema; Confusion; Diuretics, Osmotic; Emergency Treatment; Fatal Outcome	2011

Article

Year

Modelling the adverse effects associated with ecstasy use.

Addiction (Abingdon, England), 2011, Volume: 106, Issue:4

Topics: Affect; Alcohol Drinking; Anxiety; Binomial Distribution; Confusion; Dose-Response Relationship, Dru

2011

A 26-year-old woman with sudden onset cerebral edema.

Journal of emergency nursing, 2011, Volume: 37, Issue:1

Topics: Acute Disease; Adult; Brain Edema; Confusion; Diuretics, Osmotic; Emergency Treatment; Fatal Outcome

2011